COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 2979: Articles 29781-29790  | Next

Confronting COVID-19: Surging critical care capacity in Italy
Rodriguez Llanes, J. M., Castro Delgado, R., Pedersen, M. G., Arcos Gonzalez, P., Meneghini, M.
10.1101/2020.04.01.20050237 — Posted: 2020-04-06
Estimation of the Final Size of the COVID-19 Epidemic in Pakistan
Syed, F., Sibgatullah, S.
10.1101/2020.04.01.20050369 — Posted: 2020-04-06
Explaining national differences in the mortality of Covid-19: individual patient simulation model to investigate the effects of testing policy and other factors on apparent mortality.
Michaels, J. A.
10.1101/2020.04.02.20050633 — Posted: 2020-04-06
COVID-19 Outbreak in Oman: Model-Driven Impact Analysis and Challenges
Zia, K., Farooq, U.
10.1101/2020.04.02.20050666 — Posted: 2020-04-06
Inflow restrictions can prevent epidemics when contact tracing efforts are effective but have limited capacity
Malmberg, H., Britton, T.
10.1101/2020.04.01.20050401 — Posted: 2020-04-06
The effect of non-pharmaceutical interventions on COVID-19 cases, deaths and demand for hospital services in the UK: a modelling study
Davies, N. G., Kucharski, A. J., Eggo, R. M., Gimma, A., CMMID COVID-19 Working Group, , Edmunds, W. J.
10.1101/2020.04.01.20049908 — Posted: 2020-04-06
A Contribution to the Mathematical Modeling of the Corona/COVID-19 Pandemic
Baerwolff, G. K. F.
10.1101/2020.04.01.20050229 — Posted: 2020-04-06
Dynamics of COVID-19 epidemics: SEIR models underestimate peak infection rates and overestimateepidemic duration
Grant, A.
10.1101/2020.04.02.20050674 — Posted: 2020-04-06
Reduction of lymphocyte at early stage elevates severity and death risk of COVID-19 patients: a hospital-based case-cohort study
Fei, J., Fu, L., Li, Y., Xiang, H.-X., Xiang, Y., Li, M.-D., Liu, F.-F., Xu, D.-x., Zhao, H.
10.1101/2020.04.02.20050955 — Posted: 2020-04-06 Discussion: Onsite
Acute liver injury and its association with death risk of patients with COVID-19: a hospital-based prospective case-cohort study
Fu, L., Fei, J., Xu, S., Xiang, H.-X., Xiang, Y., Tan, Z.-X., Li, M.-D., Liu, F.-F., Li, Y., Han, M.-F., Li, X.-Y., Zhao, H., Xu, D.-X.
10.1101/2020.04.02.20050997 — Posted: 2020-04-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).